Prelude Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Prelude Capital Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,311	Closed	-$177K	–	2397
2019 Q1	$177K	Buy	+9,311	New	+$151K	0.01%	754
2014 Q1	–	Sell	-751	Closed	-$12K	–	2362
2013 Q4	$12K	Hold	751	–	–	﹤0.01%	1472
2013 Q3	$12K	Buy	+751	New	+$11.1K	﹤0.01%	1271

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Prelude Capital Management's OSIR Position: Q2 2019 in Review

Prelude Capital Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 9,311 shares — an estimated $177K sold.

Prelude Capital Management first reported a position in OSIR in Q3 2013 and held it in 3 quarters. The position peaked at $177K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Prelude Capital Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Prelude Capital Management sold 9,311 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $177K.
Prelude Capital Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 3 quarters.
Prelude Capital Management's Osiris Therapeutics, Inc. Common Stock position peaked at $177K in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.